Keyphrases
Zika Virus
93%
COVID-19
41%
Dengue Virus
39%
Eastern Sudan
39%
Seroprevalence
36%
Vaccine Candidate
33%
Chikungunya Virus (CHIKV)
32%
Zika Vaccine
31%
Central Sudan
29%
Zika Virus Infection
29%
Dengue
25%
Sudan
25%
Live Attenuated
23%
Systemic Immunity
19%
Mucosal Immunity
19%
Lung
18%
SARS-CoV-2 Infection
18%
Chikungunya Virus Infection
17%
Virus Infection
17%
Vaccination
16%
Mucosal Vaccine
16%
Neutralizing Antibodies
15%
SARS-CoV-2 Vaccine
15%
K18-hACE2 Mice
14%
Memory B Cells
14%
Virus-specific
14%
Immunogenicity
13%
Dengue Infection
13%
SARS-CoV-2 Variants
12%
T Cells
12%
Disease Transmission
12%
Africa
12%
Delta Variant
12%
Neurodegeneration
12%
Murine Model
12%
Omicron Variant
12%
Congenital Zika Syndrome
12%
Vaccine Antigen
12%
NS4B Inhibitors
11%
Cross-neutralization
11%
Acute Infection
11%
Yellow Fever
11%
Vertical Transmission
11%
West Nile Virus
11%
Flavivirus
10%
Inducer
10%
FluoroSpot
10%
Virus-like
10%
T Cell Response
10%
Laboratory Diagnosis
9%
Immunology and Microbiology
Zika Virus
100%
Viral Disease
64%
Severe Acute Respiratory Syndrome Coronavirus 2
59%
Dengue Virus
40%
Seroprevalence
40%
Chikungunya Virus
39%
Dengue Fever
32%
Zika Virus Vaccine
29%
T Cell
25%
Flavivirus
24%
Neutralizing Antibody
23%
COVID-19
22%
Memory B Cell
22%
Cytotoxic T-Cell
15%
Neutralization
15%
ELISA
14%
NS4B
14%
Adaptive Immune System
13%
Immunogenicity
13%
Omicron Coronavirus Variant
13%
Antibodies
13%
West Nile Virus
11%
Cell Culture
11%
Hemorrhagic Fever
11%
Adoptive Immunity
11%
Immunity
10%
Yellow Fever Virus
10%
Virus-Like Particle
10%
Antiviral Immune Response
9%
Crimean-Congo Hemorrhagic Fever Virus
9%
Spike
9%
Mycelium
9%
Host Resistance
9%
Subunit Vaccine
9%
Insect Virus
9%
Virus Nucleocapsid
9%
Upregulation
9%
Lentinula edodes
9%
Mucosal Immunity
9%
Antibody-Dependent Cell-Mediated Cytotoxicity
9%
Arbovirus
9%
Burkholderia
9%
Hemolysin
9%
Porosity
9%
Macaca fascicularis
9%
Prevalence
9%
Immune Response
8%
Cytokine Response
8%
Attenuated Vaccine
7%
Live Vaccine
7%
Medicine and Dentistry
Severe Acute Respiratory Syndrome Coronavirus 2
59%
Infection
42%
Zika Virus
22%
Chikungunya
19%
Virus Infection
15%
COVID-19
14%
Chikungunya Virus
13%
Zika Fever
12%
COVID-19 Vaccine
12%
Lung
12%
Omicron Coronavirus Variant
11%
Single Drug Dose
11%
Hemolysin
9%
Diagnosis
9%
Cohort Effect
9%
Subunit Vaccine
9%
Dengue Fever
9%
Sequela
9%
Burkholderia
9%
Supplementation
9%
Host Resistance
9%
Systemic Immunity
9%
Microparticle
9%
Yellow Fever Virus
9%
Mycelium
9%
Synapsin I
9%
Virus Like Agent
9%
Small Untranslated RNA
9%
Mucosal Immunity
9%
Virus Nucleocapsid
9%
RNA Immunization
9%
Messenger RNA
9%
K 18
9%
T Cell
8%
Transfer RNA
6%
Receptor Binding
6%
Prevalence
6%
Flavivirus
5%
Cell Death
5%
Trophoblast
5%
Immune Response
5%